Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine

K. Theys, R. J. Camacho, P. Gomes, A. M. Vandamme, S. Y. Rhee

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint Dive into the research topics of 'Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine'. Together they form a unique fingerprint.

Medicine & Life Sciences